Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Biological Safety Testing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering.
In terms of value, the market will surpass US$3.9 billion in 2024. The report predicts strong revenue growth through to 2034.
In summary, the 290+ page report provides you with the following knowledge:
- Revenue forecasts to 2034 for Biological Safety Testing Market, 2024 to 2034 Market, with forecasts for product, application, and tests, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 20 key national markets - See forecasts for the Biological Safety Testing Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
- Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Biological Safety Testing Market, 2024 to 2034.
Heightened Data Security and Privacy Concerns Hampering Market Growth
The exponential growth in data volume within the biopharmaceutical sector has intensified the imperative of ensuring data security and privacy, presenting a significant restraint in the biological safety testing market. As biopharmaceutical businesses amass vast quantities of information encompassing patient data, research findings, and regulatory compliance records, they become increasingly susceptible to malicious activities perpetrated by both criminal entities and state-sponsored actors.
Of particular concern is the vulnerability of personal health information (PHI), which, if compromised, can fuel a myriad of nefarious activities including financial and medical fraud, identity theft, and intelligence gathering for malicious purposes. Compounding this threat is the clandestine nature of breaches involving PHI, often evading detection for extended periods, thus amplifying the potential impact on individuals and organizations alike.
Moreover, the advent of sophisticated AI-driven systems introduces novel risks, as attackers may exploit vulnerabilities to undermine the integrity of underlying AI models through data poisoning attacks. Additionally, the theft of intellectual property via model stealing techniques poses a formidable challenge, further exacerbating concerns surrounding data security and privacy in the biological safety testing market.
Against a backdrop of heightened cybersecurity threats and intensified regulatory scrutiny, companies operating in the biological safety testing market face formidable challenges in safeguarding sensitive data generated throughout testing processes. The imperative of ensuring data security and privacy not only demands robust technological safeguards but also necessitates comprehensive risk management strategies and proactive compliance initiatives to mitigate potential vulnerabilities and safeguard the integrity of critical data assets. Failure to address these challenges adequately may impede market growth and erode stakeholder trust, underscoring the urgency for concerted efforts to fortify data security and privacy measures within the biological safety testing industry.
You need to discover how this will impact the Biological Safety Testing market today, and over the next 10 years:
- This 299-page report provides 99 tables and 177 charts/graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them - NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
Forecasts to 2034 and other analyses reveal commercial prospects:
- In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), Porter's Five Forces Analysis, PEST Analysis and recent developments.
Segments Covered in the Report
Product:
- Consumables
- Instruments
- Services & Others
Application Outlook:
- Cellular & Gene Therapy
- Monoclonal Antibodies (mAbs)
- Vaccines & Therapeutics
- Blood-based Therapy & Others
Tests Outlook:
- Endotoxin Tests
- Mycoplasma Tests
- Sterility Tests
- Residual Host Contamination Detection Tests
- Bioburden Tests
- Virus Safety Tests
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:
- North America
- Europe
- Asia Pacific
- Latin America
- MEA
The report also includes profiles for some of the leading companies in the Biological Safety Testing Market, 2024 to 2034, with a focus on this segment of these companies' operations.
Leading companies profiled in the report:
- Almac Group
- Charles River Laboratories
- Clean Cells
- Creative Biogene
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- Laboratory Corporation of America
- Lonza Group
- Merck KGaA
- Sartorius AG
- SGS Societe Generale de Surveillance SA
- Thermo Fisher Scientific Inc.
- Wuxi Apptec
Other companies profiled in the report:
- Bio-Rad Laboratories
- Dompe Farmaceutici
- Euformatics
- Genetrics
- Grifols
- HealthVerity, Inc.
- Illumina Inc.
- JADE Biomedical
- Macrogen
- Menarini Group
- MGI Tech Co. Ltd. (MGI)
- Novogene Europe
- Olink Holding AB
- Pall Corporation
- PathoQuest SAS
- Pensabio
- Pharmamar
- RightSource
- Samsung Biologics
- Synplogen
For more information about this report visit https://www.researchandmarkets.com/r/j4cxuj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
